The obtained CD117-positive lineage-negative phenotype, which comprised less than 2% of xenograft tumour cells, was found to have a 100 times higher tumorigenic potential than CD117-negative lineage-negative cells and resulted in the regeneration of original cancer heterogeneity in a mouse model. The gene discussed is KIT; the disease is cancer.